510(k) Report

510(k) · Cleared

Cleared

Nalu Lead Blank (50cm)

K190960510(k) TraditionalCleared Jul 11, 201990-day reviewClass II21 CFR 882.5880

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boston Scientific Neuromodulation · GZB Stimulator, Spinal-Cord, Implanted (Pain Relief)

Cleared on Jul 11, 2019 as substantially equivalent to K183047 (Boston Scientific Neuromodulation, 2019) after a 90-day review. Its family tree reaches back 7 generations to 1988.

Decided
Jul 11, 2019
Review
90 days
Class
Class II
Product code
GZB
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K883780 (1988). 9 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 7 generations backK883780 Xtrel, Model Number 3425Medtronic Vascular · 1988
  2. 6 generations backK141399 Freedom Spinal Cord Stimulator (SCS) SystemStimwave Technologies Incorporated · 2014
  3. 5 generations backK150517 Freedom Spinal Cord Stimulator SystemStimwave Technologies Incorporated · 2015
  4. 4 generations backK160600 Freedom Spinal Cord Stimulator SystemStimwave Technologies Incorporated · 2016
  5. 3 generations backK162161 Receiver Kit, Trial Kit, Spare Lead Kit, Sterile Revision Kit…Stimwave Technologies Incorporated · 2016
  6. 2 generations backK170141 Receiver Kit, Trial Kit, Spare Lead Kit, Sterile Revision Kit…Stimwave Technologies Incorporated · 2017
  7. 1 generation backK183047 Nalu Neurostimulation SystemBoston Scientific Neuromodulation · 2019 · Recalled
  8. This deviceK190960 Nalu Lead Blank (50cm)Boston Scientific Neuromodulation · 2019
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K883780Xtrel, Model Number 3425Medtronic Vascular1988—
−6K141399Freedom Spinal Cord Stimulator (SCS) SystemStimwave Technologies Incorporated2014—
−5K150517Freedom Spinal Cord Stimulator SystemStimwave Technologies Incorporated2015—
−4K160600Freedom Spinal Cord Stimulator SystemStimwave Technologies Incorporated2016—
−3K162161Receiver Kit, Trial Kit, Spare Lead Kit, Sterile Revision Kit, Wearable…Stimwave Technologies Incorporated2016—
−2K170141Receiver Kit, Trial Kit, Spare Lead Kit, Sterile Revision Kit, Wearable…Stimwave Technologies Incorporated2017—
−1K183047Nalu Neurostimulation SystemBoston Scientific Neuromodulation20191
0 (this device)K190960Nalu Lead Blank (50cm)Boston Scientific Neuromodulation2019—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510
200110
FIG. 1 — Lineage of K190960, 1988–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZB device

  1. #1 K221376 Nalu Neurostimulation Systemscore 8.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K183047Nalu Neurostimulation System
Summary page 4
…planted (Pain Relief) Class: Class II Device Classification Panel: Neurology Legally Marketed Predicate Device(s) Nalu Neurostimulation System (K183047) by Nalu Medical, Inc. Device Description The Nalu Lead Blank is an optional accessory to the Nalu Neurostimulation…
Boston Scientific Neuromodulation20191
†K170141Receiver Kit, Trial Kit, Spare Lead Kit, Sterile Revision Kit, Wearable Antenna Assembly…Stimwave Technologies Incorporated2017—

Also cleared against K183047: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 3 companies; a new generation was cleared every 8 months on median.
  • 1 of the 9 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K183047.

How does its category compare?

All GZB devices

GZB Stimulator, Spinal-Cord, Implanted (Pain Relief): FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · GZB

1in 2024

2007: 22008: 12009: 32010: 12011: 42012: 22013: 22014: 22015: 22016: 22017: 22018: 12019: 42020: 22021: 12022: 12024: 1
2007high 4 (2011) · low 0 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZB

149in 2019

2009: 62 days median2011: 67 days median2019: 149 days median
2007high 149 (2019) · low 62 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZB

1in 2010

2008: 12010: 12026 (partial year): 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZB

313in 2025

2007: 2012008: 682009: 592010: 1572011: 4712012: 1,0902013: 4,4282014: 10,8492015: 7,5072016: 4,5562017: 5,5112018: 5,2442019: 6432020: 4662021: 3322022: 2092023: 2362024: 3182025: 313
2007high 10,849 (2014) · low 59 (2009)2025

MAUDE reports naming product code GZB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—0201
20081—168
2009362059
20101—1157
20114670471
20122—01,090
20132—04,428
20142—010,849
20152—07,507
20162—04,556
20172—05,511
20181—05,244
201941490643
20202—0466
20211—0332
20221—0209
20230—0236
20241—0318
20250—0313
20260—1—

What is it indicated for?

The Nalu Neurostimulation System is indicated as the sole mitigating agent or as an adjunct to other modes of therapy used in a multidisciplinary approach for chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain.

The trial devices are solely used for trial stimulation (no longer thank 30 days) to determine efficacy before recommendation for a permanent (long term) device.

The Nalu Lead Blank is an optional accessory intended to be used as a surgical aide to insert the Nalu Neurostimulation System Leads.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K190960: Nalu Lead Blank (50cm).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K190960

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026